Changeflow GovPing Government & Legislation DEA Notice Comment Submission
Priority review Consultation Added Consultation

DEA Notice Comment Submission

Favicon for www.regulations.gov Regulations.gov Proposed Rules
Detected March 19th, 2026
Email

Summary

The Drug Enforcement Administration (DEA) is providing a portal for public comment on a notice. The comment period deadline is May 18, 2026. Interested parties can submit comments and attach files through the Regulations.gov website.

What changed

This document outlines the process for submitting public comments to the Drug Enforcement Administration (DEA) regarding a specific notice, identified by docket number DEA-2026-0431-0001. The submission portal allows individuals and organizations to provide feedback, attach supporting files up to 10MB each, and opt for email confirmation of their submission. The DEA emphasizes that any personally identifiable information submitted may be publicly disclosed.

Regulated entities, including drug manufacturers and healthcare providers, should review the DEA notice and prepare their comments. The critical deadline for submission is May 18, 2026. Compliance officers should ensure that any submitted comments adhere to the file size and type limitations and are aware that submitted information may become public record. Failure to submit comments by the deadline will preclude them from consideration.

What to do next

  1. Review the DEA notice and associated materials.
  2. Prepare and submit comments through the Regulations.gov portal by May 18, 2026.
  3. Ensure submitted comments and attachments comply with file size and type restrictions.

Source document (simplified)

Write a Comment

Commenter's Checklist
Public Comments on Federal Regulations

Comment *

5000

Attach Files

You can attach up to 20 files, but each file cannot exceed 10MB. Valid file types include: bmp, docx, gif, jpg, jpeg, pdf, png, pptx, rtf, sgml, tif, tiff, txt, wpd, xlsx, xml. Drop files here or Browse...

Email Address

Opt to receive email confirmation of submission and tracking number?
If you choose to identify as Anonymous, the option to receive an email confirmation will not be displayed. (We will never post the email address entered in the field above on Regulations.gov nor share it with anyone else.)

Tell us about yourself! I am... *

(Select an identity below)

An Individual

Yourself or another person whom
you represent with their consent

An Organization

A company, organization,
or government agency

Anonymous

A person who does not want their name
associated with the comment

Note: If you choose to identify as Anonymous, the option to enter your email address for submission confirmation is not available.

reCAPTCHA *

Solve with 2Captcha Do not submit personally identifiable information through this form. Any personally identifiable information (e.g., name, address, phone number) included in the comment form or in an attachment may be publicly disclosed in a docket or on the Internet (via Regulations.gov, a federal agency website, or a third-party, non-government website with access to publicly-disclosed data on Regulations.gov). By submitting a comment, you agree to the terms of participation and privacy notice.

Submit Comment

Please see the Privacy Notice and User Notice regarding comment submission.

Any information (e.g., personal or contact) you provide on this comment form or in an attachment may be publicly disclosed and searchable on the Internet and in a paper docket and will be provided to the Department or Agency issuing the notice. To view any additional information for submitting comments, such as anonymous or sensitive submissions, refer to the Privacy Notice and User Notice, the Federal Register notice on which you are commenting, and the Web site of the Department or Agency.

Classification

Agency
GSA
Compliance deadline
May 18th, 2026 (60 days)
Instrument
Consultation
Legal weight
Non-binding
Stage
Consultation
Change scope
Minor

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies Healthcare providers
Geographic scope
National (US)

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Pharmaceuticals Public Health

Get Government & Legislation alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when Regulations.gov Proposed Rules publishes new changes.

Free. Unsubscribe anytime.